Neuroscience

Evotec SE Reports H1 2024 Results: Challenging Year; Priority Reset for Sustainable Profitable Growth Gaining Momentum, Building on Core Strengths

Softness in market for Shared R&D Services, with H1 2024 revenues down 7% year-on-year. Continued growth of sales order book...

The Galien Foundation Announces 2024 Prix Galien USA Nominees for “Best Digital Health Solution,” “Best Medical Technology,” “Incubators, Accelerators and Equity,” and “Best Startup”

NEW YORK, Aug. 13, 2024 /PRNewswire/ -- The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences,...

MIRA Pharmaceuticals Unveils Ketamir-2’s Principal Metabolite: Nor-Ketamir – a Longer-Acting, Brain Penetrating and Selective Compound Acting on the NMDA PCP Receptor

This breakthrough in bioavailability and formulation showcases the potential for advanced, at home neurological treatments.MIAMI, FL / ACCESSWIRE / August...

LabCentral Launches “The Dish with Johannes” Video Series Profiling Biotech Entrepreneurs and Scientists Shaping the Industry’s Future

CAMBRIDGE, Mass., Aug. 7, 2024 /PRNewswire/ --  LabCentral, the premier Massachusetts-based network of coworking labs designed to accelerate high-potential biotech startups, launched...

Efficacy and Safety Data of Sotagliflozin in Patients with Type 1 Diabetes and Chronic Kidney Disease Among Three Lexicon-Sponsored Presentations at the 2024 Annual Conference of the Association of Diabetes Care & Education Specialists

10x Genomics Technology Supports TenK10K Project Led by Garvan Institute of Medical Research to Help Transform the Treatment of Complex Diseases

Garvan Institute's TenK10K Project Aims to Map 50 Million Human Cells from 10,000 People PLEASANTON, Calif., Aug. 5, 2024 /PRNewswire/...

Diagnostic Wearable Medical Devices Market size is set to grow by USD 8.76 billion from 2024-2028, Increasing prevalence of chronic diseases to boost the market growth, Technavio

ProMIS Neurosciences Showcases Novel Vaccine Approach for Maximal Targeting of Toxic Amyloid-Beta Oligomers at the 2024 Alzheimer’s Association International Conference

Preclinical data showed strong antibody responses with no measurable pro-inflammatory T cell responses against AßO and support novel approach for...

error: Content is protected !!